COSMO PHARMACEUT. EO-,26 financial statements, including revenue, expenses, profit, and loss
The total revenue of C43 for the last semiannual is 54.68 M EUR, and it's 24.12% higher compared to the previous semiannual. The net income of H2 23 is -143.24 k EUR.